Revelation Biosciences Inc (NASDAQ:REVB) currently has a daily average trading volume of 3.21M but it saw 905315 shares traded in last market. With a market cap of 2.91M USD, the company’s current market price of $0.35 came falling about -15.65 while comparing to the previous closing price of $0.41. In past 52 weeks, the stock remained buoying in the range of price level as high as $25.26 and as low as $0.28. In the recent trading on the day, stock has struck highest price mark of $0.3355 while lowest mark touched by it was $0.403.
Taking a look at 20-day trading activity of Revelation Biosciences Inc (REVB) gives us an average price of $0.4579, while its current price level is -98.62% below from 52-week high level whereas it is 23.95% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5701 while that of 200 days or SMA-200 reads an average of $1.2811. A closer look into the stock’s movement over the week reveals that its volatility is standing at 14.93% during that period while stretching the period over a month that increases to 24.76%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 36.45 which implies that the stock is in neutral territory.
Over the week, REVB’s stock price is moving -26.00% down while it is 1.75% when we observe its performance for the past one month. Year-to-date it is -24.45% down and over the past year, the stock is showing a downside performance of -97.20%.
The company is expected to be releasing its next quarterly report in February, for which analysts forecasted an EPS of -0.43 while estimate for next year EPS is -6.22.
Currently, Revelation Biosciences Inc’s total number of outstanding shares is 8.36M with 0.03% of that held by the insiders while 11.37% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -580.33% and return on equity (ROE) at -270.02%. Stock’s beta reads 0.25. Stock has a price to book (P/B) ratio of 0.56. Its return on asset (ROA) is -148.06% on average.
